0 CHECKOUT

Medicated Skin Care - Hong Kong, China

  • ID: 1573170
  • March 2011
  • Region: China, Hong Kong
  • 27 pages
  • Euromonitor International
1 of 3

The warm and humid weather in Hong Kong has always been the main factor causing many people to suffer from complaints requiring the use of topical antifungals. Recently, many newspapers have been reporting an increased incidence of skin problems. Consumers have become more informed of the causes of these skin problems, and the corresponding medication they should use.

The Medicated Skin Care in Hong Kong, China report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2006-2010, allowing you to identify the sectors driving growth. Forecasts to 2015 illustrate how the market is set to change.

Product coverage: Acne Treatments, Allergy Eye Care, Antihistamines/Allergy Remedies (Systemic), Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Child-Specific Cough, Cold and Allergy Remedies, Child-Specific Digestive Remedies, Child-Specific Medicated Skin Care, Cold Sore Treatments, Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Diarrhoeal Remedies, First Aid Kits, Gauze, Tape and Other Wound Care, Haemorrhoid Treatments, Hair Loss Treatments, READ MORE >

Note: Product cover images may vary from those shown
2 of 3

Medicated Skin Care in Hong Kong, China
Euromonitor International
March 2011
List of Contents and Tables
Executive Summary
Consumer Health Continues To Maintain Positive Performance in 2010
Products Marketed Towards Middle-aged Consumers Observe Solid Performance
International Players Lead Consumer Healthcare
Health and Beauty Retailers Continue To Be Key
Increasing Threats To Growth Over the Forecast Period
Key Trends and Developments
Increased Concern Over Child-specific Over-the-counter Products.
Domestic Companies Continue To Drive Growth Through Aggressive Marketing Support
Traditional Chinese Medicine Continues To Pose Competition for OTC Products
Products Targeted at Middle-aged Consumers Perform Well
Direct Sellers Continue To Be An Important Distribution Channel
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
Table 2 Life Expectancy at Birth 2005-2010
Market Data
Table 3 Sales of Consumer Health by Category: Value 2005-2010
Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
Table 5 Consumer Health Company Shares by Value 2006-2010
Table 6 Consumer Health Brand Shares by Value 2007-2010
Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
Table 9 Forecast Sales of Consumer Health by Category: Value 2010-2015
Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Advertising
Self-medication/self-care and Preventative Medicine
Switches
Definitions
Summary 1 Research Sources
Fortune Pharmacal Co Ltd
Strategic Direction
Key Facts
Summary 2 Fortune Pharmacal Co Ltd: Key Facts
Company Background
Production
Competitive Positioning
Summary 3 Fortune Pharmacal Co Ltd: Competitive Position 2010
Hoe Hin Pak Fah Yeow Manufacturing Ltd
Strategic Direction
Key Facts
Summary 4 Hoe Hin Pak Fah Yeow Manufacturing Ltd: Key Facts
Summary 5 Hoe Hin Pak Fah Yeow Manufacturing Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 6 Hoe Hin Pak Fah Yeow Manufacturing Ltd: Competitive Position 2010
Holistol International Ltd
Strategic Direction
Key Facts
Summary 7 Holistol International Ltd: Key Facts
Company Background
Production
Competitive Positioning
Summary 8 Holistol International Ltd: Competitive Position 2010
Nin Jiom Medicine Mfy (hong Kong) Ltd
Strategic Direction
Key Facts
Summary 9 Nin Jiom Medicine Mfy (Hong Kong) Ltd: Key Facts
Company Background
Production
Competitive Positioning
Summary 10 Nin Jiom Medicine Mfy (Hong Kong) Ltd: Competitive Position 2010
Wai Yuen Tong Medicine Holdings Ltd
Strategic Direction
Key Facts
Summary 11 Wai Yuen Tong Medicine Holdings Ltd: Key Facts
Summary 12 Wai Yuen Tong Medicine Holdings Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 13 Wai Yuen Tong Medicine Holdings Ltd: Competitive Position 2010
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 11 Sales of Medicated Skin Care by Category: Value 2005-2010
Table 12 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
Table 13 Acne Treatments by Format: % Value Breakdown 2005-2010
Table 14 Medicated Skin Care Company Shares by Value 2006-2010
Table 15 Medicated Skin Care Brand Shares by Value 2007-2010
Table 16 Acne Treatments Brand Shares by Value 2007-2010
Table 17 Hair Loss Treatments Brand Shares by Value 2007-2010
Table 18 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
Table 19 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Beiersdorf AG
  • GlaxoSmithKline PLC
  • Procter & Gamble Co.
  • Maybelline LLC.
  • Arbonne International LLC.
  • Galderma S.A.